TRDA
Entrada Therapeutics, Inc. · Healthcare
Pres, Research, Develop. Natarajan Sethuraman sold $82K of Entrada Therapeutics, Inc.
Sold$82,300
$20.03Price
4,109Shares
−2%Stake
What TRDA did after the filing
- The stock from Thu, Nov 14 open, $19.88
- −12.6%
- S&P 500, same days
- −1.2%
Measured over 30 trading days, to the Dec 30 close.
Traded Mon, Nov 11. Filed Wed, Nov 13, 4:49 PM ET, after the close. Returns use the Nov 14 open and the Dec 30 close. Not investment advice.